OKLAHOMA CITY, OK--(Marketwired - Apr 24, 2015) - On 4/21/15, a class action lawsuit was filed in the United States District Court for the Northern District of California against Cellular Biomedicine Group, Inc. (
Plaintiff seeks to recover damages on behalf of all Cellular Biomedicine Group, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Monday, June 22, 2015 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
Robin Hester FEDERMAN & SHERWOOD 10205 North Pennsylvania Avenue Oklahoma City, OK 73120 Email to: rkh@federmanlaw.com Or, visit the firm's website at www.federmanlaw.com
